Circular 27 February 2026: Availability of Nevirapine 50mg/ 5ml Suspension 100ml and 240ml
Nevirapine (NVP) suspension, together with zidovudine (AZT) syrup, is indicated for infants as part of the Prevention of Mother to Child Transmission (PMTCT) programme. There is currently a shortage of NVP 50mg/5ml suspension. The shortage has arisen due to manufacturing constraints reported by the suppliers, which have resulted in delayed production and limited availability of stock. Although th
Nevirapine (NVP) suspension, together with zidovudine (AZT) syrup, is indicated for infants as part of the Prevention of Mother to Child Transmission (PMTCT) programme.
There is currently a shortage of NVP 50mg/5ml suspension. The shortage has arisen due to manufacturing constraints reported by the suppliers, which have resulted in delayed production and limited availability of stock. Although the suppliers are committed to resuming supply in April, these timelines remain uncertain.